Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)

• Hiroshi Mukae,
• Noriho Sakamoto,
• Naoki Hosogaya,
• Kazuko Yamamoto,
• Haruo Yoshida,
• Kazuhiro Yatera,
• Koichi Izumikawa,
• Katsunori Yanagihara

Affiliations

Hiroshi Mukae

Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan

Noriho Sakamoto

Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan

Naoki Hosogaya

Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan

Kazuko Yamamoto

Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan

Haruo Yoshida

Department of Otolaryngology-Head and Neck Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Kazuhiro Yatera

Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

Koichi Izumikawa

Infection Control and Education Center, Nagasaki University Hospital, Nagasaki, Japan

Katsunori Yanagihara

Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan